Eventum Orthopaedics raises £2.5m Series A funding from Mercia and private investors to scale operations.
The Yorkshire-based medical technology company secured backing from Mercia and private investors to support production and international expansion.
Share allotment filed at Companies House
Eventum Orthopaedics is a medical technology company that has developed a sensor device designed to improve the precision and outcomes of knee replacement surgery.
Eventum Orthopaedics has secured £2.5m in a Series A funding round to advance its medical device technology. The investment was backed by Mercia through NPIF and its EIS funds, alongside private investors including specialist orthopaedic surgeons. The company will direct the capital towards initiating production, expanding its technical and sales workforce, and pursuing regulatory approval in the United States. Based in Yorkshire, the firm previously raised an initial funding round in 2021 to support product development and secure UK regulatory approval for its Quadsense device.
From the founder
"The Eventum team have done a massive amount of work in a short space of time in developing Quadsense and getting it approved for clinical use. We are now excited to start scaling up the team to commercialise the product, as well as bringing further innovations to the orthopaedics market."
John Naybour
CEO at Eventum Orthopaedics
Investor perspective
"John and his team have made great progress with the initial funding and this latest round will enable them to roll out the product to the global marketplace."
Connie Smith
Mercia
Use of funds
- 01Grow the team
- 02Continue product development
- 03Expand into international markets
Investors
Categories
About the company
Eventum Orthopaedics
Eventum Orthopaedics develops sensor technology to improve knee replacement surgery.